Mereu, Elisabetta
Lafzi, Atefeh
Moutinho, Catia
Ziegenhain, Christoph http://orcid.org/0000-0003-2208-4877
McCarthy, Davis J.
Álvarez-Varela, Adrián
Batlle, Eduard
Sagar,
Grün, Dominic http://orcid.org/0000-0002-3364-5898
Lau, Julia K.
Boutet, Stéphane C.
Sanada, Chad
Ooi, Aik
Jones, Robert C. http://orcid.org/0000-0001-7235-9854
Kaihara, Kelly
Brampton, Chris
Talaga, Yasha
Sasagawa, Yohei
Tanaka, Kaori
Hayashi, Tetsutaro
Braeuning, Caroline
Fischer, Cornelius http://orcid.org/0000-0003-0329-2435
Sauer, Sascha
Trefzer, Timo
Conrad, Christian
Adiconis, Xian
Nguyen, Lan T.
Regev, Aviv http://orcid.org/0000-0003-3293-3158
Levin, Joshua Z. http://orcid.org/0000-0002-0170-3598
Parekh, Swati http://orcid.org/0000-0002-4826-1651
Janjic, Aleksandar http://orcid.org/0000-0001-7180-5381
Wange, Lucas E. http://orcid.org/0000-0002-3275-9156
Bagnoli, Johannes W.
Enard, Wolfgang http://orcid.org/0000-0002-4056-0550
Gut, Marta
Sandberg, Rickard http://orcid.org/0000-0001-6473-1740
Nikaido, Itoshi http://orcid.org/0000-0002-7261-2570
Gut, Ivo http://orcid.org/0000-0001-7219-632X
Stegle, Oliver
Heyn, Holger http://orcid.org/0000-0002-3276-1889
Article History
Received: 7 May 2019
Revised: 18 February 2020
Accepted: 26 February 2020
First Online: 6 April 2020
Competing interests
: A.R. is a co-founder and equity holder of Celsius Therapeutics, and an SAB member of Thermo Fisher Scientific and Syros Pharmaceuticals. He is also a co-inventor on patent applications to numerous advances in single-cell genomics, including droplet-based sequencing technologies, as in PCT/US2015/0949178, and methods for expression and analysis, as in PCT/US2016/059233 and PCT/US2016/059239. K.K., C.B. and Y.T. are employed by Bio-Rad Laboratories. J.K.L. and S.C.B. are employees and shareholders at 10x Genomics, Inc. S.C.B. is a former employee and shareholder of Fluidigm Corporation. C.S. and A.O. are employed by Fluidigm. All other authors declare no conflicts of interest associated with this manuscript.